Respiratory Insufficiency

31 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Respiration Disorders

Narrower: Nasal Obstruction 1

Treatments and conditions

Respiratory Insufficiency
Treatment and conditionWhere it standsTrials
a wake prone positioning for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Apps for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Apremilast for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atibuclimab for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aviptadil for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Awake prone positioning for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Azithromycin for respiratory insufficiencyTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Cenicriviroc for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cpap for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CPAP + Dexamethasone for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cyclosporine for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cyproheptadine for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexamethasone for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dornase alfa for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Epidural spinal cord stimulation for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Famotidine + Celecoxib for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hfno for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HFNO + Dexamethasone for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxychloroquine for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxychloroquine + azithromycin + / - tocilizumab for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Icatibant for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Imatinib Mesylate for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent prone positioning instructions for respiratory insufficiencyTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Mechanical ventilation with the automated BVM compressor for respiratory insufficiencyTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Mefloquine for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mefloquine + azithromycin + / - tocilizumab for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Narsoplimab for respiratory insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Oxymetazoline for nasal obstructionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prolonged Proned Positioning for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Prone Positioning (PP) for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Proning for respiratory insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.